BPSC (Bihar) Exam > BPSC (Bihar) Questions > DCGI granted market authorization to which dr...
Start Learning for Free
DCGI granted market authorization to which drug maker to manufacture India's first indigenously developed quadrivalent Human Papillomavirus Vaccine (QHPV) against cervical cancer?
- a)Bharat Biotech
- b)Serum Institute of India
- c)Indian Immunological Limited
- d)zydus cadila
- e)None of the above/More than one of the above
Correct answer is option 'B'. Can you explain this answer?
| FREE This question is part of | Download PDF Attempt this Test |
Most Upvoted Answer
DCGI granted market authorization to which drug maker to manufacture I...
The Drugs Controller General of India (DCGI) granted market authorisation to Serum Institute of India (SII) to manufacture India’s first Quadrivalent Human Papillomavirus vaccine (qHPV) which is indigenously developed against cervical cancer.
IMPORTANT FACTS -
What is Cervical Cancer?
IMPORTANT FACTS -
What is Cervical Cancer?
- It will be an Indian vaccine for the treatment of cervical cancer in women that is both affordable and accessible.
- qHPV is the first indigenous vaccine developed in India against cervical cancer which is likely to be launched by the end of this year.
- Cervical cancer starts in the cells of the cervix, the lower part of the uterus.
- The cervix connects the body of the uterus to the vagina.
- Cancer starts when cells in the body grow out of control.
- Most cases of cervical cancer are caused by infection of the human papillomavirus (HPV), which is preventable with a vaccine.
- Cervical cancer grows slowly, so it usually has time to be detected and treated before it causes serious problems.
- Women between the ages of 35 and 44 are most likely to get this disease.
Free Test
FREE
| Start Free Test |
Community Answer
DCGI granted market authorization to which drug maker to manufacture I...
The Drugs Controller General of India (DCGI) granted market authorisation to Serum Institute of India (SII) to manufacture India’s first Quadrivalent Human Papillomavirus vaccine (qHPV) which is indigenously developed against cervical cancer.
IMPORTANT FACTS -
What is Cervical Cancer?
IMPORTANT FACTS -
What is Cervical Cancer?
- It will be an Indian vaccine for the treatment of cervical cancer in women that is both affordable and accessible.
- qHPV is the first indigenous vaccine developed in India against cervical cancer which is likely to be launched by the end of this year.
- Cervical cancer starts in the cells of the cervix, the lower part of the uterus.
- The cervix connects the body of the uterus to the vagina.
- Cancer starts when cells in the body grow out of control.
- Most cases of cervical cancer are caused by infection of the human papillomavirus (HPV), which is preventable with a vaccine.
- Cervical cancer grows slowly, so it usually has time to be detected and treated before it causes serious problems.
- Women between the ages of 35 and 44 are most likely to get this disease.
Attention BPSC (Bihar) Students!
To make sure you are not studying endlessly, EduRev has designed BPSC (Bihar) study material, with Structured Courses, Videos, & Test Series. Plus get personalized analysis, doubt solving and improvement plans to achieve a great score in BPSC (Bihar).
|
Explore Courses for BPSC (Bihar) exam
|
|
Similar BPSC (Bihar) Doubts
Top Courses for BPSC (Bihar)View all
DCGI granted market authorization to which drug maker to manufacture Indias first indigenously developed quadrivalent Human Papillomavirus Vaccine (QHPV) against cervical cancer?a)Bharat Biotechb)Serum Institute of Indiac)Indian Immunological Limitedd)zydus cadilae)None of the above/More than one of the aboveCorrect answer is option 'B'. Can you explain this answer?
Question Description
DCGI granted market authorization to which drug maker to manufacture Indias first indigenously developed quadrivalent Human Papillomavirus Vaccine (QHPV) against cervical cancer?a)Bharat Biotechb)Serum Institute of Indiac)Indian Immunological Limitedd)zydus cadilae)None of the above/More than one of the aboveCorrect answer is option 'B'. Can you explain this answer? for BPSC (Bihar) 2024 is part of BPSC (Bihar) preparation. The Question and answers have been prepared according to the BPSC (Bihar) exam syllabus. Information about DCGI granted market authorization to which drug maker to manufacture Indias first indigenously developed quadrivalent Human Papillomavirus Vaccine (QHPV) against cervical cancer?a)Bharat Biotechb)Serum Institute of Indiac)Indian Immunological Limitedd)zydus cadilae)None of the above/More than one of the aboveCorrect answer is option 'B'. Can you explain this answer? covers all topics & solutions for BPSC (Bihar) 2024 Exam. Find important definitions, questions, meanings, examples, exercises and tests below for DCGI granted market authorization to which drug maker to manufacture Indias first indigenously developed quadrivalent Human Papillomavirus Vaccine (QHPV) against cervical cancer?a)Bharat Biotechb)Serum Institute of Indiac)Indian Immunological Limitedd)zydus cadilae)None of the above/More than one of the aboveCorrect answer is option 'B'. Can you explain this answer?.
DCGI granted market authorization to which drug maker to manufacture Indias first indigenously developed quadrivalent Human Papillomavirus Vaccine (QHPV) against cervical cancer?a)Bharat Biotechb)Serum Institute of Indiac)Indian Immunological Limitedd)zydus cadilae)None of the above/More than one of the aboveCorrect answer is option 'B'. Can you explain this answer? for BPSC (Bihar) 2024 is part of BPSC (Bihar) preparation. The Question and answers have been prepared according to the BPSC (Bihar) exam syllabus. Information about DCGI granted market authorization to which drug maker to manufacture Indias first indigenously developed quadrivalent Human Papillomavirus Vaccine (QHPV) against cervical cancer?a)Bharat Biotechb)Serum Institute of Indiac)Indian Immunological Limitedd)zydus cadilae)None of the above/More than one of the aboveCorrect answer is option 'B'. Can you explain this answer? covers all topics & solutions for BPSC (Bihar) 2024 Exam. Find important definitions, questions, meanings, examples, exercises and tests below for DCGI granted market authorization to which drug maker to manufacture Indias first indigenously developed quadrivalent Human Papillomavirus Vaccine (QHPV) against cervical cancer?a)Bharat Biotechb)Serum Institute of Indiac)Indian Immunological Limitedd)zydus cadilae)None of the above/More than one of the aboveCorrect answer is option 'B'. Can you explain this answer?.
Solutions for DCGI granted market authorization to which drug maker to manufacture Indias first indigenously developed quadrivalent Human Papillomavirus Vaccine (QHPV) against cervical cancer?a)Bharat Biotechb)Serum Institute of Indiac)Indian Immunological Limitedd)zydus cadilae)None of the above/More than one of the aboveCorrect answer is option 'B'. Can you explain this answer? in English & in Hindi are available as part of our courses for BPSC (Bihar).
Download more important topics, notes, lectures and mock test series for BPSC (Bihar) Exam by signing up for free.
Here you can find the meaning of DCGI granted market authorization to which drug maker to manufacture Indias first indigenously developed quadrivalent Human Papillomavirus Vaccine (QHPV) against cervical cancer?a)Bharat Biotechb)Serum Institute of Indiac)Indian Immunological Limitedd)zydus cadilae)None of the above/More than one of the aboveCorrect answer is option 'B'. Can you explain this answer? defined & explained in the simplest way possible. Besides giving the explanation of
DCGI granted market authorization to which drug maker to manufacture Indias first indigenously developed quadrivalent Human Papillomavirus Vaccine (QHPV) against cervical cancer?a)Bharat Biotechb)Serum Institute of Indiac)Indian Immunological Limitedd)zydus cadilae)None of the above/More than one of the aboveCorrect answer is option 'B'. Can you explain this answer?, a detailed solution for DCGI granted market authorization to which drug maker to manufacture Indias first indigenously developed quadrivalent Human Papillomavirus Vaccine (QHPV) against cervical cancer?a)Bharat Biotechb)Serum Institute of Indiac)Indian Immunological Limitedd)zydus cadilae)None of the above/More than one of the aboveCorrect answer is option 'B'. Can you explain this answer? has been provided alongside types of DCGI granted market authorization to which drug maker to manufacture Indias first indigenously developed quadrivalent Human Papillomavirus Vaccine (QHPV) against cervical cancer?a)Bharat Biotechb)Serum Institute of Indiac)Indian Immunological Limitedd)zydus cadilae)None of the above/More than one of the aboveCorrect answer is option 'B'. Can you explain this answer? theory, EduRev gives you an
ample number of questions to practice DCGI granted market authorization to which drug maker to manufacture Indias first indigenously developed quadrivalent Human Papillomavirus Vaccine (QHPV) against cervical cancer?a)Bharat Biotechb)Serum Institute of Indiac)Indian Immunological Limitedd)zydus cadilae)None of the above/More than one of the aboveCorrect answer is option 'B'. Can you explain this answer? tests, examples and also practice BPSC (Bihar) tests.
|
|
Explore Courses for BPSC (Bihar) exam
|
|
Suggested Free Tests
Signup for Free!
Signup to see your scores go up within 7 days! Learn & Practice with 1000+ FREE Notes, Videos & Tests.
|
© EduRev
|
Education Revolution
|
Follow Us
|
Signup to see your scores
go up within 7 days!
Access 1000+ FREE Docs, Videos and Tests
Takes less than 10 seconds to signup